When CML Therapy Shifts: Collaborative Approaches to Treatment Changes
Claire Saxton shares insights on how physicians and caregivers can best assist patients with CML who have switched therapies.
CURE_EC_CML_Seg06_Changes
Video Player is loading.
EP: 1.Understanding CML: Your Journey from Diagnosis to Treatment
EP: 2.Navigating CML: Tools to Empower Patients and Caregivers
EP: 3.Empowering CML Caregivers: Strategies and Support Systems
EP: 4.Starting CML Treatment: Collaborative Choices for Better Outcomes
EP: 5.Open Dialogue in CML Care: Setting Expectations, Managing Side Effects, and Optimizing Patient Quality of Life
Now Viewing
EP: 6.When CML Therapy Shifts: Collaborative Approaches to Treatment Changes
EP: 7.CML Treatment: Scenarios that Necessitate Switching Therapy
EP: 8.Ensuring Informed CML Care from Diagnosis Onward
EP: 9.Advancing CML Management Towards an Ideal Patient Journey
This program was made possible with support from Novartis Pharmaceuticals.
Video content above is prompted by the following questions:
- In your experience, how can physicians and caregivers both support patients in navigating a therapy change? Which resources can best help support patients during a treatment transition?
Recent Videos
Imaging Quality in Prostate Cancer: Impact on Treatment Decision-Making
Selecting the Optimal PSMA PET Imaging Agent: Clinical Considerations and Data-Driven Decisions
CAR T in High-Risk DLBCL: Making the Right Choice in Aggressive Disease
PSMA PET Imaging Agents: Image Quality and Diagnostic Performance
Transplant-Eligible, CAR T Considered: How Do We Decide?
The Evolving Role of PSMA PET in Prostate Cancer Imaging and Management
Auto-SCT or CAR T? A Case-Based Discussion in Relapsed DLBCL
Personalizing CAR T: Making the Right Call for Each Patient
Rethinking CAR T Timing: Insights on CAR T Efficacy and Patient Selection
CAR T in the Real World: Clinician Perspectives on Outcomes, Toxicity, and Patient Management
Related Content
